RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • U.S. clears AstraZeneca over heart drug trial

    LONDON (Reuters) - The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects. The drugmaker...
  • Top U.S. lawmaker urges Hospira not to flee tax system

    WASHINGTON (Reuters) - A senior U.S. senator said on Thursday he has written to Hospira Inc and urged the drug and medical device maker not to move its tax domicile abroad to save on U.S. taxes. Citing recent reports that Hospira plans to buy the medical...
  • Auxilium drug effective against cellulite in mid-stage study

    (Reuters) - Auxilium Pharmaceuticals Inc said two doses of its drug to smoothen cellulite were statistically significant in a mid-stage study, sending its shares up nearly 8 percent. There are no FDA-approved cellulite treatments and there is little...
  • Pfizer back for AstraZeneca? Year-end move seen most likely

    LONDON (Reuters) - Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May. But while...
  • Janus' Kozlowski seeks stocks immune to market malaise

    BOSTON (Reuters) - Concerned that trends in the economy may not help stock prices much, Janus Capital Group's Dan Kozlowski is looking for companies that can help themselves. As manager of the $4.2 billion Janus Contrarian Fund, Kozlowski has posted...
  • Use of experimental Ebola drug raises red flags among medical experts

    Two American aid workers were gravely ill, fighting to survive infection with the deadly Ebola virus. A San Diego drug company had three doses of an experimental Ebola medicine that showed promise in monkeys but had never been tested in humans....
  • American Ebola patients become serum test subjects

    American Ebola patients become serum test subjects
    There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
  • Connecticut Growers Tending Marijuana Crops, Preparing For Sales Starting In September

    Connecticut Growers Tending Marijuana Crops, Preparing For Sales Starting In September
    For months, Advanced Grow Labs LLC — one of Connecticut's four medical marijuana growing companies — slogged through the process of competing for a state license, securing local zoning approvals, and outfitting a building to state...
  • SEC reviewing attempted takeover of Botox maker Allergan

    The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Ackman's hedge fund, Pershing Square Capital Management,...
  • 'Plantibodies' drugs advance as big pharma stands aside

    LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...
  • Cohen, Point72 must face SAC insider trading lawsuit-judge

    NEW YORK (Reuters) - A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the...